After more than a year since the emergence of Covid-19, the global road to recovery will be a long and challenging one. What are the key lessons that life sciences companies can take away from the world’s pandemic year?
External suppliers are used extensively throughout the pharma industry, but how can new client-supplier relationships be managed and defined most effectively? Pfizer’s senior director for drug product supply external strategy Francis Dumont makes the case for streamlining the RFI process.
It goes without saying that the coronavirus pandemic has had an unprecedented impact on economies and industries worldwide, but within the pharmaceutical space, Covid-19 has completely re-shaped the clinical supply chain. Amy Malkani explores the key issues.